(Q37022435)

English

Assessment of methodological quality and sources of variation in the magnitude of vaccine efficacy: a systematic review of studies from 1960 to 2005 reporting immunization with Moraxella bovis vaccines in young cattle

scientific article published on 26 October 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

Europe PubMed Central

Assessment of methodological quality and sources of variation in the magnitude of vaccine efficacy: a systematic review of studies from 1960 to 2005 reporting immunization with Moraxella bovis vaccines in young cattle (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

0 references

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

Moraxella bovis

object named as

Moraxella bovis

1 reference

based on heuristic

inferred from title

author name string

Burns MJ

1

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

O'Connor AM

2

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

language of work or name

0 references

publication date

26 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

144-152

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Immunogenicity of a Moraxella bovis bacterin containing attachment and cornea-degrading enzyme antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

Vaccination against infectious bovine keratoconjunctivitis: protective efficacy and antibody response induced by pili of homologous and heterologous strains of Moraxella bovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

The protective efficacy of pili from different strains of Moraxella bovis within the same serogroup against infectious bovine keratoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

A Moraxella bovis pili vaccine produced by recombinant DNA technology for the prevention of infectious bovine keratoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

A haemolytic cell-free preparation ofMoraxella bovisconfers protection against infectious bovine keratoconjunctivitis

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

based on heuristic

inferred from DOI database lookup

The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

Effectiveness of a cytolysin-enriched vaccine for protection of cattle against infectious bovine keratoconjunctivitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

Treatment of Moraxella bovis infections in calves using a long-acting oxytetracycline formulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

Vaccination of cattle with Mycoplasma bovoculi antigens: evidence for field immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

Attachment of Moraxella bovis to calf corneal cells and inhibition by antiserum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

Infectious bovine keratoconjunctivitis vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

Meta-analyses in vaccinology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

Why is evidence-based medicine so harsh on vaccines? An exploration of the method and its natural biases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

A meta-analysis comparing the effect of vaccines against Mycoplasma hyopneumoniae on daily weight gain in pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.014

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.10.014

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37022435&oldid=2110029043"